Pluri Inc. — Director's Dealing 2016

Jun 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2016-05-30

Reporting Person: SHORRER DORON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-30	Common Stock	S	12346	$1.5215	Disposed	570208	Indirect

Footnotes

F1: The sale was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for a per share sales price of NIS 5.85, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.845 per U.S. dollar.

F2: The reporting person's sale of 12,346 shares of PSTI common stock reported herein is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the reporting person's purchase of 12,346 shares of PSTI common stock reported on February 17, 2016. The reporting person has paid PSTI, $8,816.28 representing the full amount of the profit realized in connection with these short-swing transactions.